RFAM SEC filings, in plain English
Everything RF Acquisition III has filed with the SEC that we hold — 26 filings, newest first, 24 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: Amended Schedule 13G beneficial ownership report (SEC CIK [0001167557-26-000158]) submitted by AQR Capital Management, LLC, AQR Capital Management Holdings, LLC, and AQR Arbitrage, LLC. The filing updates a prior Section 13(d) disclosure. The provided excerpt omits adjusted share counts, ownership percentages, acquisition or disposition dates, and purpose statements, so the magnitude or direction of any beneficial ownership shift cannot be determined from the text alone. Why it matters: In a SPAC setting marked externally by a trust/share value of $10.13 and an extension deadline of 2027-11-17, amendments to institutional holdings can reflect portfolio rebalancing, arbitrage positioning, or changes in redemption liquidity expectations that may indirectly influence sponsor negotiation leverage and secondary trading volume. Because the document excerpt contains no percentage thresholds, transaction volumes, or intent declarations, it does not independently confirm alterations to the redemption timeline, trust liquidation mechanics, or sponsor conduct. The filing makes zero claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; any substantive operational or financial assertions are entirely absent from this text.
What changed: Quarterly report on Form 10-Q for the period ended June 30, 2026, filed by RF Acquisition Corp III (RFAM), a blank-check company formed to pursue a business combination, with a focus on Asian deep-technology sectors. The Company reported that on July 9, 2026, it entered into a definitive Business Combination Agreement with HCC Healthcare Pte. Ltd., a Singapore healthcare company, valuing HCC Healthcare at $500 million on a fully-diluted basis ($10.00 per share). The transaction will convert each SPAC share into one HCC Healthcare share and each SPAC right into one-tenth of an HCC Healthcare share. The trust account held $101,273,496 as of June 30, 2026, equivalent to $10.13 per public share (10,000,000 shares). Sponsor Alfa 30 Limited transferred 900,000 founder shares to third-party designees. The Company also reported interest income on the trust of $870,264 for the quarter and $1,273,496 for the nine months. No material changes to risk factors were disclosed. Why it matters: This filing confirms the target and deal structure for investors tracking business combination progress, provides the trust account value per share ($10.13) and redemption mechanics, outlines sponsor conduct (founder share transfers, waivers), and notes the absence of any extension or adverse sponsor actions. The business combination agreement is a nonrecognized subsequent event, with closing conditions including shareholder approval and regulatory clearances.
What changed vs 2026-04-30trust $100.4M → $101.3M +1%trust account, sponsor loans outstanding, mandate language +11 moved · 3 with no prior record of ours
- Trust account
- $100.4M$101.3M
- Sponsor loans outstanding
- $150K · unchanged
- Mandate language
- The Company intends to pursue a Business Combination with a … · unchanged
- Redeemable shares
- 10.0M · unchanged
SpacBrain reads this as $870,264 was added to the trust between the two filings.
The clause “1,600 $ Prepaid expenses 53,948 30,900 Total Current Assets 945,548 30,900 Cash held in Trust Account 101,273,496 - Deferred offering costs - 82,594 Total Assets $ 102,219,044 $ 113,494 Liabilities, Ordinary Shares Subject to Possible”…
The clause …“Initial Public Offering. On February 25, 2026, the Company repaid the total outstanding balance of the promissory note amounting to $ 150,000 and the note is terminated. Due to Sponsor As of June 30, 2026, the balance of $ 46,071 due”…
The clause …“3,933,333 and 3,833,333 ordinary shares issued and outstanding (excluding 10,000,000 and 0 shares subject to possible redemption), respectively. As of September 30, 2025, the issued and outstanding ordinary shares include an”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Business Combination Agreement (BCA) filed as an 8-K, including merger agreement, support agreements, registration rights agreement, and press release. RF Acquisition Corp III entered into a definitive Business Combination Agreement with HCC Healthcare Pte. Ltd. on July 9, 2026. The merger consideration is one newly issued HCC ordinary share per RFAM ordinary share, and one-tenth of an HCC share per RFAM right. The pre-transaction equity value of HCC is $500M. The trust account had $101,273,495.71 as of June 30, 2026. The agreement includes a 270-day outside date (April 5, 2027). The Company will pay Acquiror's transaction expenses up to $7.5M and extension fees. The Founder (Alfa 30) agreed to a 6-month lock-up. HCC shareholders (Hsiao family) also agreed to a 6-month lock-up. Why it matters: This is the definitive deal announcement for RFAM. The trust per share is approximately $7.27 based on the stated trust amount and shares outstanding, which is below the $10.13 implied by the status, suggesting significant redemptions may have already occurred or the trust value has decreased. The deal values HCC at $500M. The Company funding extensions and transaction expenses reduces the cash available to the combined company. The 270-day deadline is tight for a Q4 2026 closing. The lock-up periods are standard but the sponsor's 6-month lock-up is typical. The business is a healthcare platform in Taiwan with a large long-term care network.
What changed: A Rule 425 written communication (Form 8-K) announcing the entry into a definitive Business Combination Agreement between RF Acquisition Corp III (RFAM) and HCC Healthcare Pte. Ltd., a Singapore healthcare company operating in Taiwan, along with full text of the merger agreement, voting and lock-up agreements, and a press release. This filing changes the SPAC's status from pre-deal to DEAL_ANNOUNCED. The definitive agreement sets a pre-transaction equity value of $500 million for HCC Healthcare, with each SPAC share converting into one new share of the combined company and each SPAC right converting into one-tenth of a share. The trust balance as of June 30, 2026 was at least $101,273,495.71, implying a per-share trust value of approximately $7.27 based on 13,933,333 shares outstanding. The SPAC's deadline is 2027-11-17, and the agreement has a 270-day outside date (April 5, 2027). The deal is subject to shareholder approval, SEC effectiveness, and Nasdaq listing. Founder (Alfa 30 Limited) and certain company shareholders agreed to six-month lock-ups post-closing. The transaction is expected to close in Q4 2026. Why it matters: For redemption calendar watchers: The trust value per share is approximately $7.27, not $10.13 as previously indicated, which may affect redemption decisions. The 270-day outside date is well within the SPAC's 2027-11-17 deadline, reducing extension risk. The deal includes a $75 million financing target (PIPE or trust proceeds) and 3 million incentive shares reserved for non-redemption or PIPE investors. Sponsor conduct: Founder agreed to vote for the deal, not redeem, and lock up for six months—a positive signal. The target is a large healthcare platform in Taiwan with over 120 long-term care facilities and 9,000 beds, addressing a growing super-aged demographic. The filing contains extensive representations and warranties, conditions, and termination provisions (e.g., 45-day cure for company breach, 30-day for SPAC breach). Investors should monitor for SEC comment letters, shareholder vote timing, and any redemption statistics.
What changed: A Schedule 13G beneficial ownership report submitted on May 13, 2026, by AQR Capital Management, LLC, AQR Capital Management Holdings, LLC, and AQR Arbitrage, LLC. According to the filing, the three named AQR-affiliated entities are reported as beneficial owners. The text enumerates no share quantities, acquisition or disposition dates, purchase prices, aggregate percentage thresholds, or source of funds. It contains no language addressing the November 17, 2027 redemption deadline, the $10.13 per-share trust account, any proposed business combination extension, merger approval timelines, or sponsor governance and compensation conduct. Why it matters: Because the submission discloses only entity names and lacks all operational and positional data, it does not recalibrate the mechanical parameters surrounding shareholder redemption windows or the stated $10.13 trust value. Routing through an arbitrage affiliate often reflects pre-close portfolio hedging, but without explicit position sizes, effective control assertions, or change-of-control triggers, the filing provides no actionable signal regarding liquidity demand, dilution math, or deal execution speed. Investors tracking the 2027 expiration horizon or potential proxy filings for an extension must look to subsequent 13D amendments, 424B prospectuses, or tender offer statements for material shifts in the timeline or trust calculus.
What changed: Quarterly report (Form 10-Q) for RF Acquisition Corp III for the quarter ended March 31, 2026, its second fiscal quarter. This is the Company's first 10-Q as a reporting public company following its IPO on February 17, 2026. The filing reports the IPO closing, private placement, and trust formation. Key incremental information: (a) On March 17, 2026, the Company entered into a non-binding letter of intent with a prospective target for a potential business combination. (b) Cash held in the Trust Account as of March 31, 2026, was $100,403,232, with a redemption value of $10.04 per share. (c) Net income for the six-month period was $673,033, driven by interest earned on the Trust Account ($403,232) and the change in fair value of the forfeited over-allotment liability ($422,000). (d) The Company reiterated its deadline of 21 months from the IPO closing (November 17, 2027) to complete an initial business combination. (e) The over-allotment option was forfeited on February 19, 2026. (f) The Company has $933,390 in cash outside the Trust Account to fund search and operations. Why it matters: This filing is the first operational update post-IPO. The most material disclosure for investors is the entry into a non-binding LOI on March 17, 2026, confirming an active deal process. The trust value ($100.4M, ~$10.04/share) and the November 17, 2027, deadline are now confirmed. The filing also states management has concluded the Company has sufficient working capital, reducing near-term liquidity risk. The forfeiture of the over-allotment and the accretion of carrying value to redemption value are now quantified.
trust account, redeemable shares, sponsor loans outstanding +1nothing moved · 4 with no prior record of ours
- Trust account
- not previously extracted$100.4M
- Redeemable shares
- not previously extracted10.0M
- Sponsor loans outstanding
- $150K · unchanged
- Mandate language
- The Company intends to pursue a Business Combination with a … · unchanged
The clause “390 $ Prepaid expenses 81,353 30,900 Total Current Assets 1,014,743 30,900 Cash held in Trust Account 100,403,232 - Deferred offering costs - 82,594 Total Assets $ 101,417,975 $ 113,494 Liabilities, Ordinary Shares Subject to Possible”…
The clause …“3,933,333 and 3,833,333 ordinary shares issued and outstanding (excluding 10,000,000 and 0 shares subject to possible redemption), respectively. As of September 30, 2025, the issued and outstanding ordinary shares include an”…
The clause …“Initial Public Offering. On February 25, 2026, the Company repaid the total outstanding balance of the promissory note amounting to $ 150,000 and the note is terminated. Due to Sponsor As of March 31, 2026, the balance of $ 16,071 due”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Form 10-Q quarterly report for the period ended December 31, 2025, prior to the SPAC's IPO completion, filed after the IPO but reflecting pre-IPO financials. This is the first 10-Q since inception. The balance sheet as of December 31, 2025 shows no cash, deferred offering costs of $758,705, a working capital deficit of $299,606, and a promissory note from the sponsor of $98,688. The IPO closed on February 17, 2026 (after quarter-end), placing $100,000,000 in the trust account ($10.00 per share) and raising $3,500,000 from a private placement. The underwriters' over-allotment option was forfeited, resulting in the cancellation of 500,000 founder shares. The combination period is 21 months from the IPO closing, or November 17, 2027. No business combination has been announced. Why it matters: Establishes the initial trust value of $10.00 per share and the redemption deadline of November 17, 2027. Provides details on sponsor economics, including founder share forfeiture and valuation assumptions for EBC founder shares (23.6% probability of business combination). Confirms the SPAC has not yet identified a target. Important for shareholders monitoring redemption timelines and trust value.
What changed: Form 8-K current report disclosing the consummation of an initial public offering, a concurrent private placement, the subsequent forfeiture of an underwriters’ over-allotment option, and accompanying audited financial statements and exhibits. According to the filing, RF Acquisition Corp III completed its initial public offering on February 17, 2026, selling 10,000,000 units at $10.00 per unit, generating gross proceeds of $100,000,000. Simultaneously, the company closed a private placement of 350,000 units at $10.00 per unit for $3,500,000; the registrant states these were purchased by sponsor Alfa 30 Limited and its designees (250,000 units) and underwriter EarlyBirdCapital, Inc., acting as representative (100,000 units). The audited balance sheet dated February 17, 2026, shows $100,155,913 deposited in the trust account, which management attributes to an over-funding of $155,913 wired by the sponsor. On February 19, 2026, the underwriters notified the company they would not exercise their 45-day over-allotment option to purchase up to 1,500,000 additional units, triggering the forfeiture of 500,000 founder shares originally issued to the sponsor. The filing details $4,708,386 in total transaction costs, including a $2,000,000 cash underwriting fee, $501,500 representing the fair value of 250,000 shares issued to EarlyBirdCapital, and $1,747,800 tied to 900,000 founder shares transferred to third-party designees. The sponsor recorded a $150,000 promissory note due at IPO closing and contracted to pay the sponsor a fixed administration fee of $10,000 per month for office space, utilities, and secretarial support beginning February 12, 2026. The registrant established a 21-month Combination Period from the IPO closing date to consummate an initial business combination. Why it matters: The documented trust balance of $100,155,913 sets the precise redemption pool and liquidation ceiling for the 10,000,000 public shares, with the registrant noting redemptions will be paid at a pro-rata share of that amount plus accrued interest (net of taxes). The underwriters’ decision to forfeit the over-allotment permanently fixes the outstanding public unit count at 10,000,000 and reduces sponsor equity by 500,000 shares, altering post-merger ownership concentration without touching public trust capital. The 21-month deadline dictates the final redemption window; absent a shareholder-approved extension, the filing mandates the company cease operations, redeem 100% of public shares from the trust (less $100,000 for dissolution expenses), and liquidate. Per the registrant’s stated strategy, management holds broad discretion but intends to concentrate its acquisition search on businesses located in Asia within the deep technology sector, specifically citing artificial intelligence, quantum computing, and biotechnology. Exchange listing rules cited in the filing require the combined entity to acquire a target with a fair market value equal to at least 80% of the trust account assets (excluding released interest). Leadership is identified as Chief Executive Officer Tse Meng Ng, who executed the report, and audit oversight rests with Marcum Asia CPAs LLP, which issued an opinion on the February 17, 2026 balance sheet. The company discloses zero operating revenues, classifies itself as an emerging growth company electing not to opt out of the JOBS Act extended transition period, and acknowledges geopolitical and macroeconomic risks, including sanctions and supply chain disruptions stemming from the Russia-Ukraine conflict and the Israel-Hamas conflict, which could adversely affect target sourcing.
What changed: A Form 8-K current report (Items 8.01 Other Events; Item 9.01 Financial Statements and Exhibits) accompanied by Exhibit 99.1, a corporate press release announcing the elective decoupling of listed securities. Per the press release signed by Chairman and CEO Tse Meng Ng, starting February 26, 2026, holders of the 10,000,000 units sold in the initial public offering may elect to separate the underlying ordinary shares (ticker RFAM) and rights (ticker RFAMR), where each right entitles the holder to one-tenth of one ordinary share upon an initial business combination. Unseparated units continue trading as RFAMU. Separation requires broker coordination with transfer agent Continental Stock Transfer & Trust Company. EarlyBirdCapital, Inc. acted as the sole book-running manager, and the registration statement became effective January 30, 2026. This procedural milestone does not modify the November 17, 2027 liquidation deadline, the $10.13 per-share trust balance, or any existing merger negotiations. Why it matters: Separate trading provides immediate liquidity for shareholders to manage risk exposure without triggering redemptions or altering trust mechanics. It confirms post-IPO clearing and tracking systems are operational ahead of the 2027 deadline and verifies standard underwriting and transfer-agent logistics are functioning. According to the 'About RF Acquisition Corp III' portion of the press release, management plans to target Asian deep technology firms (artificial intelligence, quantum computing, biotechnology) but expressly excludes companies based in or deriving most operations from Greater China. These strategic boundaries establish the addressable market scope for investors monitoring deal progression, while the mechanical update carries no force on the redemption calendar, valuation floor, or sponsor extension rights.
What changed: SEC Form 3 — initial statement of beneficial ownership, functioning here as a routine compliance exhibit. Alfa 30 Ltd, identified as a 10% owner, is reported to hold 4,083,333 shares directly. Because the filing records an initial ownership position rather than a trade or amendment, it does not alter the redemption deadline, adjust the trust account balance, trigger extension voting, or move merger negotiations forward. Why it matters: For investors monitoring capital structure and sponsor alignment, the report formally anchors Alfa 30 Ltd’s 4,083,333-share block as of 2026-02-23 without introducing derivative instruments or lock-up modifications. The document contains no operational or strategic claims: it references no customers, revenue targets, market sizing data, technology roadmaps, partnership agreements, litigation exposures, or personnel shifts. All assertions are sourced directly from the reporting party’s submission, and every numeric figure matches the text verbatim with no external computation or trust-convention imported.
What changed: FORM 3 — insider ownership report. Per the SEC submission, Ng Tse Meng (identified as director, CEO and Chairman, and 10% owner) maintains an indirect holding of 4,083,000 shares in RF Acquisition Corp III. The filing reports no acquisitions, dispositions, or derivative exercises. It makes no mention of alterations to the $10.13 per-share trust balance, the 2027-11-17 redemption deadline, any extension proposal, target acquisition progress, or sponsor conduct adjustments. Why it matters: Because the document exclusively catalogs a static equity position without accompanying transaction activity, it does not introduce secondary selling pressure that could affect share supply, voting thresholds, or trust distribution timelines. For investors monitoring the stated 2027-11-17 deadline and $10.13 trust value, this filing confirms those parameters remain undisturbed. Subsequent Form 4 filings or proxy materials will be required to disclose any actual trades, extension votes, or announced business combinations that could materially impact redemption decisions or sponsor alignment.
What changed: A SEC Form 3 routine compliance exhibit and initial insider ownership report, submitted on 2026-02-23, identifying reporting person Tham Chee Soon (director, Chief Financial Officer) of RF Acquisition Corp III. The filing states there are “No non-derivative transactions or holdings reported,” confirming no changes to insider equity positions, no impact on the $10.13 per share trust value, and no alteration to the 2027-11-17 redemption deadline or any deal announcement mechanics. Why it matters: For investors tracking redemption calendars, trust value, extensions, deal progress, and sponsor conduct, this document establishes a zero-activity regulatory baseline: no insider accumulation or liquidation that might signal private-side restructuring, liquidity demand, or confidence shifts ahead of the combination window. Beyond the officer titles and the explicit absence of reported transactions, it contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel, and therefore does not advance the SPAC’s transaction timeline or modify shareholder redemption rights.
What changed: A routine compliance exhibit — a Form 3 Statement of Changes of Beneficial Ownership filed under Section 16(a) of the Securities Exchange Act. The filing explicitly states no non-derivative transactions or holdings are reported for Wen Ryan Lee, director of RF Acquisition Corp III, meaning no change in insider equity allocation occurred that would affect public float composition, voting weight distributions, sponsor conduct obligations, extension negotiation leverage, trust account governance, or the mathematical backdrop for shareholder redemptions ahead of the calendar deadline. Why it matters: Investors tracking redemption mechanics, trust value preservation, and post-announcement deal execution will note that the document contains zero claims regarding customers, revenue streams, total addressable market sizing, strategic pivots, proprietary technology, commercial partnerships, active litigation, or additional executive appointments. Per the filing text, the sole content is the regulatory attestation of an unpopulated equity schedule, leaving capital structure dynamics, trust distribution waterfalls, and the execution timeline entirely unaffected by director-level trading activity.
What changed: SEC Form 3 insider ownership report. This Form 3 documents the initial or ongoing beneficial ownership disclosure for Director Shng Yunn Chinn in RF Acquisition Corp III, filed 2026-02-23 under SEC file number 0001829126-26-001591. The filer explicitly reports no non-derivative transactions or holdings. This notation leaves the SPAC’s trust value of $10.13 per share, its DEAL_ANNOUNCED status, and the 2027-11-17 deadline completely unchanged, with no adjustment to redemption mechanics, extension triggers, or sponsor capital positioning. Why it matters: For investors monitoring redemption timelines and sponsor alignment, this routine compliance snapshot confirms no reported insider share purchases or dispositions that would influence public float calculations or signal shifted confidence ahead of the 2027-11-17 deadline. The filing contains no substantive operational or financial assertions; there are no claimed details regarding customer pipelines, revenue trajectories, market sizing, commercial strategy, technology roadmaps, partnership structures, ongoing litigation, or executive personnel shifts attributed to the board or management team. Lacking transactional data or forward-looking statements, the Form 3 serves as a static regulatory baseline rather than a catalyst for trust recalibration or deal progression.
What changed: SEC Form 3 insider ownership report filed by RF Acquisition Corp III director Lee Low Tuan on 2026-02-23, identified by accession number 0001829126-26-001580. The report filed by Director Lee Low Tuan explicitly states 'No non-derivative transactions or holdings reported,' confirming zero changes to insider equity positions. Consequently, the stated trust value of $10.13 per share, the 2027-11-17 deadline, and the DEAL_ANNOUNCED status face no new insider buying, selling, or pledging activity that would signal a shift in sponsorship conduct or influence near-term redemption mechanics. Why it matters: Investors monitoring the February 2026 reporting period receive no updated claims regarding target company pipelines, customer contracts, revenue projections, or financing structures. Because Director Lee Low Tuan’s filing records no equity movement, there is no fresh personnel or balance-sheet data to adjust extension voting likelihoods, liquidation risk models, or sponsor alignment assessments beyond the baseline tracking sheet.
What changed: Form 8-K filed by RF Acquisition Corp III to report the closing of its initial public offering on February 17, 2026, including the entry into standard SPAC IPO agreements such as the underwriting agreement, trust agreement, letter agreement with sponsor and insiders, registration rights, private placement purchase agreements, administrative services agreement, business combination marketing agreement, indemnification agreement, and securities escrow agreement. The filing also appoints initial independent directors and adopts the amended charter. The SPAC completed its IPO of 10,000,000 units at $10.00 per unit, generating $100 million in gross proceeds. Simultaneously, it sold 350,000 private placement units (250,000 to the sponsor and 100,000 to EarlyBirdCapital) for $3.5 million. Total trust deposit is $100,000,000 (plus interest). The company appointed its board of directors: Ryan Lee Wen, Tuan Lee Low, and Yunn Chinn Shng as independent directors, and formed audit and compensation committees. The charter was amended and restated, establishing a 21-month deadline to complete a business combination (through November 17, 2027, subject to possible extension). The company disclosed in a press release that it intends to focus its search on businesses in Asia within the deep technology sector, including artificial intelligence, quantum computing, and biotechnology. Why it matters: This filing establishes the fundamental SPAC structure: trust value of $10.13 per share (per prompt metadata), redemption deadline, lock-up periods for founder shares (six months post-business combination) and private placement units (until business combination), and the contractual framework (voting agreements, trust waivers, expense reimbursement, and indemnification). The stated target focus on Asia deep tech provides investors with initial strategic direction. All subsequent de-SPAC activity will be measured against these baseline documents and the trust account mechanics.
What changed: Refiled IPO prospectus under Rule 424(b)(3) (Reg. No. 333-290947), correcting a typographical error in the Underwriting section on page 152 of the version filed the same day: RF Acquisition Corp III, a Cayman Islands company, offering $100,000,000 of 10,000,000 units at $10.00, each unit one ordinary share plus one right for one-tenth of a share on closing a business combination, with a 45-day over-allotment option for 1,500,000 units through EarlyBirdCapital. The stated focus is Asian deep technology (AI, quantum computing, biotechnology), with an express prohibition on combining with any company based in or majority-operating in Greater China. Deadline is 21 months from IPO closing, extended to 24 months if a business-combination proxy is filed within 21 months; failing that, 100% of public shares are redeemed from trust less up to $100,000 of liquidation expenses. Sponsor Alfa 30 Limited and EBC buy 350,000 private units at $10.00 ($3,500,000; 250,000 sponsor / 100,000 EBC) plus up to 30,000 more on over-allotment to keep $10.00 per public unit in trust. Initial shareholders hold 3,833,333 founder shares (up to 500,000 forfeitable) at about $0.0065 per share, roughly 25% of post-IPO shares. Public shareholders acting alone or in concert may not redeem more than 15% of the shares sold in the offering without consent. Why it matters: A 25% founder promote (higher than the usual 20%) and a 21-month clock make this a tight, dilutive vehicle; the explicit Greater China exclusion narrows the target universe for an Asia deep-tech mandate, and the 15% redemption cap limits large holders' exit at the vote.
What changed: A Form 8-A for registration of certain classes of securities under Section 12(b) of the Securities Exchange Act of 1934, filed by RF Acquisition Corp III to list units, ordinary shares, and rights on The Nasdaq Stock Market LLC. This filing does not alter, extend, or comment on the redemption deadline, trust value, or extension mechanics. It formally registers the Company’s units, ordinary shares, and rights for public listing and incorporates by reference the securities description from the registration statement initially filed on October 17, 2025 (File No. 333-290947). Why it matters: The document specifies the exact tradable capital structure being listed: units comprising one ordinary share and one right; ordinary shares carrying a par value of $0.0001 per share; and rights entitling holders to receive one-tenth of one ordinary share upon completion of an initial business combination. Tse Meng Ng executed the filing as Chief Executive Officer on February 12, 2026. While procedurally routine for exchange listing compliance, it locks in the precise instruments governing SPAC liquidity, shareholder conversion rights, and post-deal equity distribution.
What changed: A Rule 424(b)(4) preliminary prospectus formally pricing RF Acquisition III’s initial public offering of 10,000,000 units at $10.00 each. Why it matters: Beyond mechanics, the prospectus details the firm's strategic focus, governance tensions, and capital structure that shape investor risk. According to the filing, the management team will target Asia-based deep technology businesses in artificial intelligence, quantum computing, and biotechnology, while explicitly avoiding companies based in or operating primarily in Greater China.
What changed: Routine compliance exhibit / post-effective amendment to a Form S-1 registration statement (Amendment No. 4), filed as an exhibit-only submission to deliver the independent accounting firm’s consent (Exhibit 23.3) and restate Part II disclosures. The filing inserts Exhibit 23.3, granting Marcum Asia CPAs LLP’s consent to reference its October 17, 2025 audit report on the company’s financial statements. It restates Part II Item 13, disclosing estimated offering expenses of $700,000 (excluding underwriting discounts): $300,000 legal fees, $50,000 accounting fees, $35,000 SEC/FINRA expenses, $80,000 NASDAQ listing and filing fees, $25,000 printing and engraving expenses, $190,000 miscellaneous expenses (attributed by the registrant to approximate annual director and officer liability insurance premiums), and $20,000 trustee and transfer agent fees. Item 15 confirms recent unregistered sales: Alfa 30 Limited (the Sponsor) acquired 3,833,333 founder shares for $25,000 ($0.0065 per share) on September 30, 2025; EarlyBirdCapital, Inc. (EBC) received 250,000 ordinary shares for approximately $1,630 (approximately $0.0065 per share) on October 9, 2025. The registrant states that initial shareholders and EBC agreed to purchase 350,000 Private Placement Units (250,000 by Sponsor, 100,000 by EBC), and if over-allotment is exercised, will buy up to 30,000 additional units at $10.00 per unit to maintain $10.00 per unit sold to the public in the Trust Account. Why it matters: The disclosure maps the sponsor’s capital deployment and private placement mechanics directly to the trust account maintenance obligation, showing how initial shareholders and EBC will inject capital to sustain the stated $10.00 per unit trust benchmark during any over-allotment. The registrant notes that officers and directors have agreed to waive any right, title, interest, or claim in the trust account for services rendered, preserving trust balance integrity for redeeming public shareholders. The $190,000 miscellaneous expense allocation explicitly covers D&O insurance premiums until a business combination completes, indicating standard governance provisioning rather than commercial operation. Personnel updates show CEO Tse Meng Ng, CFO Chee Soon Tham, and directors Tuan Lee Low, Ryan Lee Wen, and Yunn Chinn Shng executed the filing. While the document does not modify the redemption deadline or the $10.13 trust-per-share metric cited in tracking databases, it provides a complete, audited-consent-backed ledger of issuer expenses, warrant/option-like private placement triggers, and indemnification boundaries under Cayman Islands law. No new business combination targets, revenue projections, or customer claims are presented, consistent with its status as a late-stage registration administration document.
What changed: Amendment No. 3 to a Registration Statement on Form S-1 (S-1/A) — a preliminary prospectus for an initial public offering of 10,000,000 units by a blank check company seeking to acquire an Asia-based deep technology business. This filing updates the registration statement for RF Acquisition Corp III's IPO. No new business combination target has been announced, and the filing remains a pre-effective IPO prospectus subject to completion. Key updated terms include: a trust/share amount of $10.00 per unit ($100 million total, $115 million with overallotment); a 21-month deadline from closing to complete a business combination (extendable to 24 months if a proxy statement is filed within 21 months); no specified maximum redemption threshold; and a 15% per-shareholder cap on redemptions if a shareholder vote is held and tender offer rules are not used. The indemnification and lock-up provisions are reiterated, as is the sponsor's agreement to indemnify the trust account for claims reducing funds below $10.00 per share, subject to waivers. Why it matters: The filing is significant because it provides the first detailed public disclosure of the SPAC's structure, sponsorship, and investment terms. It confirms the sponsor, Alfa 30 Limited (beneficially owned by CEO Tse Meng Ng), has a significant ownership stake (25%) acquired at $0.0065 per share, creating a conflict of interest where insiders have strong incentives to complete any deal, even if value-destructive, to avoid losing their investment. It also highlights a history of related-party transactions with prior SPACs (RF Acquisition Corp and RF Acquisition Corp II) by the same management team, which may present pre-existing fiduciary duties that could limit the pool of available targets. The filing's risk factors (e.g., no specified maximum redemption, potential for a shareholder vote to be avoided) are material for investors assessing redemption risk.
What changed: Amendment No. 2 to Registration Statement on Form S-1 (S-1/A) for an initial public offering of units by RF Acquisition Corp III, a blank check company seeking to acquire a business in Asia deep technology sector. This amendment updates the prospectus to include audited financial statements for the period from September 15, 2025 (inception) through September 30, 2025, and the independent auditor's consent (Exhibit 23.3). No changes to the offering size, trust amount, or redemption mechanics from the previous filing. The preliminary prospectus remains subject to completion. Why it matters: This filing is a step toward SEC declaring the IPO registration effective, enabling RF Acquisition Corp III to complete its initial public offering and begin its search for a business combination. It provides investors with the final terms of the offering, including trust size ($100M), redemption rights, sponsor compensation, and conflict disclosures. The trust value per share is $10.00, with a deadline of 21 months from closing (or 24 months if a proxy is filed within 21 months). No target business has been identified yet.
What changed: Amendment No. 1 to a Registration Statement on Form S-1 for an initial public offering of 10,000,000 units (each consisting of one ordinary share and one right) of a blank-check company seeking a business combination target in Asia deep tech (excluding Greater China). Amendment No. 1 updates the preliminary prospectus primarily to refile certain exhibits (legal opinion, trust and escrow agreements, consent) and to refresh all dates, pricing, and quantitative disclosures to December 19, 2025. No new deal target, extension vote, or change in sponsor conduct is introduced. All redemption/trust mechanics — $10.00/unit trust deposit, 21-month deadline (24-month if proxy filed), per-share redemption at trust value plus interest, 15% redemption cap if a shareholder vote is held, and sponsor indemnity limited to trust-shortfall claims — remain identical to the initial S-1. The document is a routine SEC compliance step to progress toward IPO effectiveness. Why it matters: This filing confirms that RFAM is proceeding with its IPO on the same terms as originally proposed and has cleared an SEC comment cycle to the point of refiling exhibits. The appearance of comfort letters and legal opinions alongside the updated registration statement signals that the underwriter and counsel are prepared for the offering to go effective. For redemption-calendar trackers, the deadline remains 2027-11-17 (21 months from a presumed December 2025 IPO closing). For deal-progress monitoring, the sponsor’s prior SPAC track record (RF Acquisition Corp I completed with GCL Global; RF Acquisition Corp II signed with Nanyang Biologics) provides context but no new target. The ongoing working-capital deficit ($73,672 at 9/30/25) and audit going-concern paragraph underscore that the IPO cash is critical for survival.
What changed: Form S-1 registration statement (preliminary prospectus) for a new SPAC IPO — RF Acquisition Corp III is registering 10,000,000 units at $10.00 for a $100 million blank-check offering. This is a new registration; no prior public filings exist for this SPAC. The SPAC has a trust of $10.00 per share, a 21-month deadline (24 months if a proxy is filed), and intends to focus on Asia deep-tech (AI, quantum, biotech) but excludes any company based in or with majority operations in Greater China. Sponsor is Alfa 30 Limited, solely owned by CEO Tse Meng Ng. Underwriter is EarlyBirdCapital. Why it matters: This filing establishes the SPAC's baseline terms: trust redemption at $10.00 per share plus interest, no specified maximum redemption threshold, a 15%-of-shares cap on redemption if a shareholder vote is used, and a founder-share lock-up of six months post-business-combination. The exclusion of Greater China targets is an explicit constraint. The sponsor's prior SPAC track record (RF Acquisition Corp closed GCL Global in Feb 2025; RF Acquisition Corp II signed Nanyang Biologics in Oct 2025) provides deal-flow context but no guarantee of future results.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.